# Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer

> **NCT00983424** · PHASE1 · COMPLETED · sponsor: **Northwestern University** · enrollment: 14 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Cyclosporins
- **DRUG:** nab-paclitaxel

## Key facts

- **NCT ID:** NCT00983424
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2013-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00983424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00983424, "Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00983424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*